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Abstract
Background: Body Mass Index (BMI) is widely used to assess the impact of obesity on cardiometabolic risk in
children but it does not always relate to central obesity and varies with growth and maturation. Waist-to-Height
Ratio (WHtR) is a relatively constant anthropometric index of abdominal obesity across different age, sex or racial
groups. However, information is scant on the utility of WHtR in assessing the status of abdominal obesity and
related cardiometabolic risk profile among normal weight and overweight/obese children, categorized according to
the accepted BMI threshold values.
Methods: Cross-sectional cardiometabolic risk factor variables on 3091 black and white children (56% white, 50%
male), 4-18 years of age were used. Based on the age-, race- and sex-specific percentiles of BMI, the children were
classified as normal weight (5th - 85th percentiles) and overweight/obese (≥ 85th percentile). The risk profiles of
each group based on the WHtR (<0.5, no central obesity versus ≥ 0.5, central obesity) were compared.
Results: 9.2% of the children in the normal weight group were centrally obese (WHtR ≥0.5) and 19.8% among the
overweight/obese were not (WHtR < 0.5). On multivariate analysis the normal weight centrally obese children were
1.66, 2.01, 1.47 and 2.05 times more likely to have significant adverse levels of LDL cholesterol, HDL cholesterol,
triglycerides and insulin, respectively. In addition to having a higher prevalence of parental history of type 2
diabetes mellitus, the normal weight central obesity group showed a significantly higher prevalence of metabolic
syndrome (p < 0.0001). In the overweight/obese group, those without central obesity were 0.53 and 0.27 times less
likely to have significant adverse levels of HDL cholesterol and HOMA-IR, respectively (p < 0.05), as compared to
those with central obesity. These overweight/obese children without central obesity also showed significantly
lower prevalence of parental history of hypertension (p = 0.002), type 2 diabetes mellitus (p = 0.03) and metabolic
syndrome (p < 0.0001).
Conclusion: WHtR not only detects central obesity and related adverse cardiometabolic risk among normal weight
children, but also identifies those without such conditions among the overweight/obese children, which has
implications for pediatric primary care practice.
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Childhood obesity is reaching epidemic proportions
worldwide [1]. Although childhood obesity is a well
recognized risk factor for developing cardiovascular dis-
ease and type 2 diabetes mellitus in adulthood, excess
central (intra-abdominal) body fat distribution may be
more related to these diseases than peripheral distribu-
tion [2]. Body Mass Index (BMI) is widely used as a mea-
sure to evaluate the impact of obesity on cardiovascular
and metabolic risk factors, both in children and adults.
However, in children, the BMI measures have to be
expressed as z scores or percentiles relative to age and
sex as BMI is strongly related to growth and maturation
[3]. Moreover, BMI does not always relate to central obe-
sity [4] and it cannot differentiate muscle mass from
bone and fat mass [5]. Waist-to-Height Ratio (WHtR)
has been proposed as an easily measurable anthropo-
metric index for detection of central obesity and to assess
associations between cardiometabolic risk factor variables
and central intra-abdominal obesity [6-10]. Studies in
adults have shown that it is possible to identify not only
those with normal weight having an adverse cardiometa-
bolic risk profile but also those with overweight/obese
condition having normal metabolic risk profile [2,5,11].
Although studies relating BMI and WHtR to cardiovas-
cular (CV) disease risk factors in children and adoles-
cents are emerging [6,12-17], information is scant on the
utility of WHtR in assessing the status of abdominal obe-
sity and related cardiometabolic risk profile among nor-
mal weight and overweight/obese children. The objective
of this current study was to examine this aspect in chil-
dren enrolled in the Bogalusa Heart Study, a biracial
(black-white) community-based study of the natural
history of CV disease since childhood [18].
Methods
Study population
T h ep r e s e n ts t u d ys a m p l ew a sd e r i v e df r o m3 2 3 8c h i l -
dren, 4-18 years of age (mean age 10.98 years, 50% male,
56% white). After excluding those with age-, race- and
sex-specific BMI less than the 5
th percentile (n = 147),
the subjects were divided into two groups: the normal
weight group (n = 2581), with BMI between the 5
th and
the 85
th percentiles; the overweight/obese group (n =
510), with BMI ≥ 85
th percentile. Using the previously
recommended cut-point [6,8,14], children in each group
were sub-divided based on their WHtR: centrally obese
(WHtR ≥ 0.5) or non-centrally obese (WHtR < 0.5). The
protocols of this study were approved by the Institutional
Review Board of the Tulane University Health Sciences
Center. Informed consent was obtained from all the par-
ticipants, for those under 18 years of age, consent of
a parent/guardian was obtained.
General examination
Standardized protocols were used by trained examiners
[19]. The subjects were instructed to fast overnight
before screening. Anthropometric and blood pressure
measurements were made in replicate, and the mean
values were used. The BMI was calculated as the weight
in kilograms divided by the square of height in meters.
Waist circumference was measured midway between the
lowest border of rib cage and the upper border of iliac
crest while the child was standing. Blood pressure mea-
surements were obtained using a mercury sphygmoman-
ometer, on the right arm of the participants who were
in a relaxed sitting position, by two trained observers,
each recording three measurements. The first and the
fourth Korotkoff phases were recorded for systolic and
diastolic blood pressures respectively, and average levels
were used for analysis.
Laboratory Analyses
Serum cholesterol and triglyceride levels were assayed
using enzymatic procedures (Abbott VP, North Chicago,
Illinois) [20,21]. The levels of lipoprotein cholesterol
were analyzed by a combination of heparin-calcium pre-
cipitation and agar-agarose gel electrophoresis proce-
dures [22]. Plasma insulin measurements were obtained
with the use of a commercial radio-immunoassay kit
(Phadebas Insulin Kit; Pharmacia Diagnostics, Piscat-
away, NJ). Glucose was measured as part of a multiple
chemistry profile (SMA 20) by a glucose oxidase method.
The laboratory is monitored for precision and accuracy
of lipid measurements by the Lipid Standardization and
Surveillance Program of the Centers for Disease Control
and Prevention (Atlanta, GA). Insulin resistance status
was assessed as homeostasis model assessment of insulin
resistance (HOMA-IR) according to the formula
described [23]: insulin (μU/mL) × glucose (mmol/L)/22.5.
Statistical Analysis
All statistical analyses were performed using Statistical
Analysis Systems, version 9.1 (SAS Institute, Cary, North
Carolina). Continuous variables were tested for normality
using the Kolmogorov-Smirnov test. The values of insu-
lin and HOMA-IR were log transformed to improve the
normality of distribution. The differences in the mean
values (mean ± standard error) of the cardiometabolic
risk factor variables between the sub-groups were tested
separately for each of the two groups (normal weight and
overweight/obese) by analysis of covariance, adjusting for
age, race and sex wherever necessary. In multivariate ana-
lyses, independent associations between the cardiometa-
bolic risk factor variables and central obesity were
examined for both groups using separate multivariate
logistic regression analysis models, taking the presence or
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Page 2 of 7absence of central obesity (yes/no) as the dependent
variable. Adverse levels were defined as age-, race- and
sex- specific top tertiles of each cardiometabolic risk
variable (except for HDL cholesterol) and the lower two
tertiles were used as the reference group; bottom tertile
versus the rest for HDL cholesterol. Categorical variables
and prevalence rates were compared using c
2 tests. With
respect to metabolic syndrome, although there is a
plethora of definitions used in studies of children, we
used the one outlined by Cook et al [24].
Results
Figure 1 illustrates the prevalence of central obesity
among normal weight and overweight/obese groups.
Based on the WHtR (<0.5 vs. ≥ 0.5), 9.2% of children in
the normal weight group had central obesity (n = 238),
and 19.8% of the overweight/obese group did not
(n = 101).
A ss h o w ni nT a b l e .1 ,t h ec e n t r a l l yo b e s en o r m a l
weight group, in addition to having significantly more
males than females, showed higher age-, race- and sex-
adjusted mean levels of systolic and diastolic blood pres-
sures, mean arterial pressure (MAP), LDL cholesterol,
triglycerides (TG), TG/HDL ratio, glucose, insulin and
HOMA-IR, and lower mean levels of HDL cholesterol
than the non-centrally obese normal weight group,
whereas in the overweight/obese group, the levels of all
the risk factor variables except diastolic blood pressure,
MAP and glucose were significantly lower (higher levels
of HDL cholesterol) in children without central obesity
as compared to those who were centrally obese.
The results of the multivariate logistic regression ana-
lysis are presented in Table 2. After adjusting for age,
race and sex, the centrally obese normal weight group
was 1.66, 1.47, and 2.05 times more likely than the non-
centrally obese normal weight (reference group) to have
significantly elevated levels of LDL cholesterol, triglycer-
ides and insulin, respectively, and 2.01 times more likely
to have significantly lower levels of HDL cholesterol. On
the other hand, the odds of having adverse levels of
HDL cholesterol and HOMA-IR were 0.53 and 0.27
times lower, respectively, in the non-centrally obese
overweight/obese group versus the reference centrally
obese overweight/obese group.
Figure 2. demonstrates the prevalence of metabolic
syndrome according to the WHtR groups in the normal
weight and the overweight/obese children. As expected,
5.88% of the centrally obese normal weight subjects had
metabolic syndrome as compared to only 0.26% of the
normal weight without central obesity (p < 0.0001).
Figure 1 Prevalence of Status of Central Obesity (Waist-to-Height Ratio <0.5 vs. ≥ 0.5) among Normal Weight and Overweight/Obese
Children: The Bogalusa Heart Study.
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central obesity showed the presence of metabolic syn-
d r o m ew h e r e a st h ep r e v a l e n c ei nt h ec e n t r a l l yo b e s e
overweight/obese was as high as 21.27% (p < 0.0001).
As listed in Table 3., the prevalence of parental history
of type 2 diabetes mellitus was significantly higher in
individuals in the normal weight group having central
obesity (11.71% vs. 6.63%, p = 0.007). The overweight/
obese children without central obesity had a significantly
lower prevalence with respect to parental history of
hypertension (23.86% vs. 41.31%, p = 0.002) and type 2
diabetes mellitus (8.24% vs. 17.66%, p = 0.03) as com-
pared to those with central obesity.
Discussion
In this present cross-sectional, community-based study we
used WHtR as a simple anthropometric index to identify
the status of central (visceral) obesity and cardiometabolic
risk factor profiles in groups of normal weight and over-
weight/obese children, selected based on traditional BMI
criteria. Earlier studies in adults and children have sup-
ported the practicality of this convenient anthropometric
Table 1 Mean levels of cardiometabolic risk factor variables in normal weight and overweight/obese children by
waist-to-height ratio: The Bogalusa Heart Study
NORMAL WEIGHT (BMI- 5th to 85th percentiles)
# OVERWEIGHT/OBESE (BMI ≥ 85th percentile)
#
Variable Waist-to-Height Ratio Waist-to-Height Ratio
<0.5 (n = 2343) ≥0.5 (n = 238) p-value <0.5 (n = 101) ≥0.5 (n = 409) p-value
Age 10.9 (0.07) 11.36 (0.23) 0.08 8.5 (0.34) 11.6 (0.16) <0.0001
Male % 48.5 57.6 0.007 46.5 50.6 0.46
White % 53.4 74.0 <0.0001 33.7 60.1 <0.0001
Systolic Blood Pressure (mm Hg) 101.8 (0.16) 104.0 (0.51) <0.0001 105.0 (0.88) 107.2 (0.41) 0.02
Diastolic Blood Pressure (mm Hg) 61.3 (0.14) 62.9 (0.45) 0.0008 64.4 (0.68) 64.9 (0.32) 0.47
Mean Arterial Pressure (mm Hg) 74.7 (0.13) 76.5 (0.42) <0.0001 77.9 (0.63) 79.0 (0.30) 0.12
LDL Cholesterol (mg/dl) 100.2 (0.52) 110.4 (1.65) <0.0001 103.8 (2.86) 111.7 (1.36) 0.01
Triglycerides (mg/dl) 72.1 (0.73) 95.4 (2.32) <0.0001 88.4 (5.57) 108.5 (2.73) 0.002
HDL Cholesterol (mg/dl) 54.4 (0.23) 49.1 (0.75) <0.0001 49.9 (1.03) 46.8 (0.49) 0.008
TG/HDL Ratio 1.4 (0.02) 2.2 (0.06) <0.0001 1.9 (0.16) 2.5 (0.07) 0.003
Glucose (mg/dl) 79.4 (0.17) 81.9 (0.56) <0.0001 81.1 (0.84) 81.9 (0.40) 0.39
Insulin (μU/ml)* 9.9 (0.13) 13.9 (0.43) <0.0001 13.6 (1.37) 19.4 (0.63) <0.0001
Insulin Resistance Index (HOMA-IR)* 1.9 (0.03) 2.8 (0.09) <0.0001 2.8 (0.31) 3.9 (0.14) <0.0001
Data presented as means (standard error) for continuous variables and percentages for categorical variables.
*Values presented are the adjusted means, but log values were used for comparisons.
#BMI percentiles were age-, race- and sex-specific.
Continuous variables (except for age) were adjusted for age, race and gender.
HOMA-IR = Homeostasis model assessment of insulin resistance; TG/HDL Ratio = Triglyceride/HDL Cholesterol Ratio.
Table 2 Odds Ratios and 95% CI for adverse levels of cardiometabolic risk factor variables in normal weight and
overweight/obese children: The Bogalusa Heart Study
NORMAL WEIGHT (n = 2581) (BMI- 5th to 85th
percentiles)
# (Referenced to waist-to-height
ratio <0.5)
OVERWEIGHT/OBESE (n = 510) (BMI ≥ 85th
percentile)
# (Referenced to waist-to-height
ratio ≥0.5)
Independent Variable (Top tertile vs. rest)* OR 95% CI p-value OR 95% CI p-value
Mean Arterial Pressure (mm Hg) 1.30 0.92-1.83 0.13 1.10 0.60-2.03 0.75
LDL Cholesterol (mg/dl) 1.66 1.18-2.32 0.003 0.61 0.34-1.10 0.10
Triglycerides (mg/dl) 1.47 1.02-2.11 0.03 0.59 0.32-1.07 0.08
HDL Cholesterol (mg/dl) 2.01 1.44-2.79 <0.0001 0.53 0.30-0.96 0.03
Glucose (mg/dl) 1.13 0.77-1.66 0.51 1.44 0.78-2.67 0.23
Insulin (μU/ml) 2.05 1.16-3.62 0.01 2.09 0.59-7.38 0.24
Insulin Resistance Index (HOMA-IR) 1.43 0.78-2.62 0.23 0.27 0.08-0.90 0.03
*Bottom tertile vs. the rest for HDL cholesterol. Tertiles were age-, race- and sex-specific. Models were age-, race- and sex-adjusted. All variables were included in
both the models.
# BMI percentiles were age-, race- and sex-specific.
HOMA-IR = Homeostasis model assessment of insulin resistance; CI = Confidence Intervals.
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Page 4 of 7index [6,8,10,15-17]. We found that while the normal
weight children with central obesity had adverse levels of
cardiometabolic risk factor variables as compared to those
without central obesity, the overweight/obese without cen-
tral obesity had significantly lower levels in relation to
those with central obesity. These observations in children
are in accordance with the emerging concepts that recog-
nize subsets of obesity and support the existence of meta-
bolically obese normal weight, and metabolically benign
obesity phenotypes in adults [2,10,11,25]. These findings
support the pathophysiologic role of intra-abdominal body
fat distribution in determining interrelated cardiometa-
bolic risk variables collectively recognized as metabolic
syndrome [26-29]. It is now well recognized that central
adiposity acts as a complex and highly active endocrine
organ resulting in a variety of hormones and cytokines
(tumor necrosis factor-a, interleukin-6 etc.), which in turn
can play an important role in the dysregulation of inflam-
matory, metabolic and hemodynamic processes in the
body through various mechanisms including hepatic lipo-
genesis and hepatic insulin resistance, release of free fatty
acids from adipocytes, macrophage infiltration into the
adipose tissue, adipose renin-angiotensin-aldosterone
system and sympathetic nervous system activation and
ectopic lipid storage [11,30,31].
Central obesity status regardless of normal weight or
overweight/obesity condition in children is related to
parental history of hypertension and type 2 diabetes,
underscoring the familial nature of the relationship
shown earlier in the Bogalusa Heart Study cohort
[32,33]. Even though the overweight/obese without cen-
tral obesity had a lower prevalence of parental history of
CV disease the difference did not reach the level of
significance. This may be explained by the fact that our
Figure 2 Prevalence of Metabolic Syndrome in Normal Weight and Overweight/Obese Children According to Waist-to-Height Ratio:
The Bogalusa Heart Study.
Table 3 Prevalence of parental history of hypertension, cardiovascular disease and type 2 diabetes in normal weight
and overweight/obese children by waist-to-height ratio: The Bogalusa Heart Study
NORMAL WEIGHT (n = 2581) (BMI- 5th to 85th
percentiles)
#
OVERWEIGHT/OBESE (n = 510) (BMI ≥ 85th
percentile)
#
Prevalence (%) Waist-to-Height Ratio Waist-to-Height Ratio
<0.5 ≥0.5 p-value <0.5 ≥0.5 p-value
Parental history of hypertension 26.9 27.1 0.97 23.9 41.3 0.002
Parental history of cardiovascular disease 8.4 9.2 0.65 5.8 12.8 0.06
Parental history of type 2 diabetes mellitus 6.6 11.7 0.007 8.2 17.7 0.03
# BMI percentiles were age-, race- and sex-specific.
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disease is higher than that of type 2 diabetes mellitus.
We believe that the above mentioned observations
have important public health implications. The tradi-
tional cut-offs for BMI may underestimate the cardio-
metabolic risk in the normal weight and overestimate
the same in the overweight/obese children while WHtR
may be more sensitive in identifying the children at risk,
especially at a population level, and provide a better
estimate of the overall risk. As normal weight children
may have already developed central obesity, health
awareness efforts must include such children and advo-
cate lifestyle changes, which may be easier to achieve in
this group, before they develop overt obesity and its
complications.
This community-based study had certain limitations in
that it lacked direct assessments of pubertal status, body
fat mass and distribution and in vivo insulin action.
Instead, we used well-established surrogate measures that
are simple and appropriate at the population level.
Furthermore, this study being observational and cross-
sectional in nature, could not address the issue of
causality.
Conclusion
The findings of the present study emphasize the utility
of WHtR not only in detecting central intra-abdominal
obesity and related cardiometabolic risk among normal
weight children, but also in identifying those without
central obesity and a healthy risk factor profiles among
the overweight/obese children. Thus, WHtR has a
potential for wider use as a simple measure to assess
cardiometabolic risk in pediatric primary care practice.
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